Search

everythinglearnresearchcommunity

for

Search:↓

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

Bortezomib chemotherapy can cause temporary skin rashes.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Cedrol may be an effective treatment for colorectal cancer.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Liposomal curcumin improves skin cancer treatment effectiveness while sparing normal cells.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

A special gel with medicine helps prevent melanoma from coming back after surgery.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Suppressing ODC activity reduces tumor growth in hair follicles.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.